Correction to: Effects of liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
- PMID: 40022170
- PMCID: PMC11871594
- DOI: 10.1186/s12931-025-03161-5
Correction to: Effects of liver × receptor agonist treatment on signal transduction pathways in acute lung inflammation
Figures


Erratum for
-
Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.Respir Res. 2010 Feb 22;11(1):19. doi: 10.1186/1465-9921-11-19. Respir Res. 2010. PMID: 20175894 Free PMC article.
Similar articles
-
Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.Respir Res. 2010 Feb 22;11(1):19. doi: 10.1186/1465-9921-11-19. Respir Res. 2010. PMID: 20175894 Free PMC article.
-
Liver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-κB and JNK/p38 MAPK Signal Pathways.Biomed Res Int. 2017;2017:4652695. doi: 10.1155/2017/4652695. Epub 2017 Apr 5. Biomed Res Int. 2017. PMID: 28480221 Free PMC article.
-
The Synthetic LXR Agonist GW3965 Attenuates Phosgene-Induced Acute Lung Injury Through the Modulation of PI3K/Akt and NF-κB Signalling Pathways.Basic Clin Pharmacol Toxicol. 2025 Jun;136(6):e70045. doi: 10.1111/bcpt.70045. Basic Clin Pharmacol Toxicol. 2025. PMID: 40312968 Free PMC article.
-
Obesity, inflammation, and lung injury (OILI): the good.Mediators Inflamm. 2014;2014:978463. doi: 10.1155/2014/978463. Epub 2014 May 11. Mediators Inflamm. 2014. PMID: 24899788 Free PMC article. Review.
-
Targeting liver X receptors in inflammation.Expert Opin Ther Targets. 2013 Aug;17(8):977-90. doi: 10.1517/14728222.2013.806490. Epub 2013 Jun 6. Expert Opin Ther Targets. 2013. PMID: 23738533 Review.
References
Publication types
LinkOut - more resources
Full Text Sources